Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryRevolving Doors: Weil hires Kirkland secondaries partner as Orrick targets Cadwalader againLaw firmsKate Peacock14 Apr 2026Trading places: Kirkland launches Phildaelphia transactions practice as Sidley hires Cravath ECM partnerLaw firmsWill Lewallen10 Apr 2026Revolving Doors: Simpson Thacher launches in Singapore as Ropes, Clifford Chance build in ParisLaw firmsEliza Winter7 Apr 2026Hogan Lovells and Cadwalader partners approve largest ever law firm mergerLaw firmsKate Peacock15 Apr 2026HSF Kramer leads on £1.4bn Ivy empire saleLaw firmsEliza Winter13 Apr 2026Ropes & Gray adds new private equity partner as Milan office growsLaw firmsWill Lewallen13 Apr 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025